Loading insider details...
Latest Form 4 (Sep 24, 2026): Purchase of 5,102 ENGN shares, $10.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 24, 2026 | enGene Therapeutics Inc. (ENGN) | Purchase | 5,102 | $10.1K |
| Jun 17, 2026 | enGene Therapeutics Inc. (ENGN) | Grant/Award | 31,000 | n/a |
| Apr 23, 2026 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to Issuer | 66,660 | n/a |
| Nov 7, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to Issuer | 66,660 | n/a |
| Jul 10, 2025 | enGene Holdings Inc. (ENGN) | Grant/Award | 45,000 | n/a |
| Jun 4, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 22,500 | n/a |
| May 28, 2024 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 32,335 | n/a |
| Jan 19, 2024 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 66,660 | n/a |
| Jun 21, 2021 | Arcus Biosciences, Inc. (RCUS) | Sale | 3,047 | $73.5K |
| Apr 26, 2021 | Arcus Biosciences, Inc. (RCUS) | Sale | 4,133 | $129.7K |